Key result
Patients with Takotsubo syndrome presenting with a non-ACS phenotype had a nearly 2.3-fold higher risk of 30-day mortality and a 2.4-fold higher risk of long-term mortality compared to those with an ACS-like presentation.
Why the study?
Does a non-ACS presentation of Takotsubo Syndrome increase the risk of mortality compared to an ACS-like presentation?
Does a non-ACS presentation of Takotsubo Syndrome increase the risk of mortality compared to an ACS-like presentation?
Answers are grounded in this paper and cite their sources.
Takotsubo syndrome patients presenting without typical ACS symptoms represent a high-risk phenotype with significantly increased short- and long-term mortality, highlighting the need for presentation-specific risk assessment and management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) conducted an editorial in Takotsubo syndrome (n=421). Non-ACS presentation vs. ACS-like phenotype was evaluated on 30-day mortality (2.3-fold higher risk). Patients with Takotsubo syndrome presenting with a non-ACS phenotype had a nearly 2.3-fold higher risk of 30-day mortality and a 2.4-fold higher risk of long-term mortality compared to those with an ACS-like presentation.
Synapse has enriched 10 related papers. Consider them for comparative context: